Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
TNGX
#1555
Tango Therapeutics, Inc.
25.3
3
USD
+5.23%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+5.23%
Aylık Değişim
+46.16%
6 aylık değişim
+163.31%
Yıllık Değişim
+1804.51%
Önceki Kapanış
24.0
7
Open
25.3
3
Bid
Ask
Low
25.3
3
High
25.3
3
Hacim
109
Piyasalar
ABD Borsası
Sağlık Hizmetleri
TNGX
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
108.11 M
108.39 M
111.26 M
134.59 M
142.69 M
—
Valuation ratios
Enterprise value
264.52 M
90.07 M
530.38 M
1.07 B
1.15 B
2.84 B
Price to earnings ratio
-2.6
-1.14
-3.91
-9.23
-10.18
-24.46
Price to sales ratio
8.02
3.63
23.03
14.68
16.5
57.84
Price to cash flow ratio
-2.57
-1.11
-3.79
-6.43
-7.41
-18.73
Price to book ratio
1.69
0.18
0.77
1.42
2.97
5.34
Enterprise value to EBITDA ratio
-1.85
-0.63
-3.43
-9.94
-10.57
-24.56
Profitability ratios
Return on assets %
-0.12
-0.15
-0.16
0.08
-0.1
-0.33
Return on equity %
-0.19
-0.24
-0.29
0.1
-0.11
-0.54
Return on invested capital %
-215.81
-222.67
-212.3
85.35
-305.53
-655.15
Gross margin %
100
100
100
100
—
—
Operating margin %
-993.93
-788.76
-1 287.87
26.15
—
—
EBITDA margin %
-978.86
-777.23
-1 268.22
27.18
—
—
Net margin %
-915.21
-739.54
-1 221.41
29.52
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.98
6.26
4.75
8.88
16.32
36.21
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.02
0.01
0.24
0
0.27
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.34
-0.38
-0.33
-0.26
-0.26
-1.23
EBIT per share
-0.37
-0.39
-0.37
0.12
-0.36
-1
EBITDA per share
-0.37
-0.38
-0.36
0.12
-0.36
-0.98
Total debt per share
—
—
—
—
—
—
Cash per share
2.36
1.96
1.64
1.3
2.95
7.85
Net current asset value per share
2.44
2.04
1.72
1.39
3.05
8.19
Tangible book value per share
1.83
1.51
1.22
1.36
2.98
7.07
Working capital per share
2.09
1.71
1.36
1.23
2.86
7.16
Book value per share
1.83
1.51
1.22
1.36
2.98
7.07
Haberler
Tango Therapeutics hissesi 22,21 dolar ile zirve yaptı
Leerink, Tango Therapeutics’in hisse hedefini PDAC verileriyle yükseltti
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
Tango Therapeutics başkanı 572 bin dolarlık hisse sattı
Tango Therapeutics hissesi 21,84 dolarda rekor kırdı
Tango Therapeutics başkanı 241 bin dolarlık hisse sattı
Tango Therapeutics hissesi 19,83 dolarla rekor kırdı
Tango Therapeutics hissesi 17,64 dolarla zirve yaptı
Tango Therapeutics stock hits 52-week high at $17.64
Stifel, Tango Therapeutics için hisse hedefini yükseltti
Stifel raises Tango Therapeutics stock price target on PRMT5 data
Tango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 Promise (NASDAQ:TNGX)